NEUROTROPHIC HEPTAPEPTIDE · RESEARCH HUB
Semax Research Hub — ACTH Fragment Neurotrophic Studies
Semax is a synthetic heptapeptide analogue of ACTH (4-10) widely cited in Russian-language nootropic, neurotrophic and neuroprotective research literature.
What this hub covers
- ACTH (4-10) heptapeptide analog structure
- BDNF and NGF upregulation in published models
- Nootropic and neuroprotective research literature
- Comparison to Selank (anxiolytic neuropeptide)
- Intranasal vs parenteral research formats
Semax research articles
All research → Nootropic Research
Semax vs Selank Research Comparison
Two heptapeptides with distinct mechanisms studied in neurotrophic, anxiolytic, and neuroprotective research contexts — a side-by-side examination for laboratory reference.
Read article → Comparison
Selank vs Semax: Nootropic Peptide Comparison
Compare Selank and Semax heptapeptides in anxiolytic, cognitive, and neurotrophic research models.
Read article →Related research hubs
Researchers studying Semax commonly cross-reference these compounds.
Semax research FAQ
- What is Semax?
- Semax is a synthetic heptapeptide derived from the ACTH (4-10) sequence, widely cited in Russian-language neurotrophic, nootropic and neuroprotective research literature.
- How does Semax differ from Selank?
- Semax is an ACTH-fragment analogue most cited for nootropic and neurotrophic activity (BDNF/NGF upregulation); Selank is a tuftsin-derived peptide most cited for anxiolytic activity. They are structurally and functionally distinct.
All content on this hub is provided strictly for laboratory research purposes. Compounds listed are not for human or veterinary consumption. See our research-use disclosure for full terms.